IRIS
BENFAREMO, Devis
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.571
EU - Europa 1.693
AS - Asia 1.568
SA - Sud America 333
AF - Africa 138
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.307
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.501
SG - Singapore 520
IT - Italia 482
VN - Vietnam 353
RU - Federazione Russa 303
CN - Cina 275
BR - Brasile 251
HK - Hong Kong 146
DE - Germania 131
IE - Irlanda 131
UA - Ucraina 126
SE - Svezia 118
FR - Francia 111
GB - Regno Unito 81
IN - India 61
CI - Costa d'Avorio 60
FI - Finlandia 54
DK - Danimarca 31
TR - Turchia 31
CA - Canada 29
MX - Messico 29
NL - Olanda 29
BD - Bangladesh 28
AR - Argentina 26
MA - Marocco 26
JP - Giappone 25
PL - Polonia 25
AT - Austria 22
KR - Corea 21
IQ - Iraq 19
ZA - Sudafrica 19
CO - Colombia 15
TW - Taiwan 12
BE - Belgio 11
EC - Ecuador 11
ES - Italia 9
PH - Filippine 9
UZ - Uzbekistan 9
VE - Venezuela 9
SA - Arabia Saudita 8
TN - Tunisia 8
ID - Indonesia 7
CL - Cile 6
EG - Egitto 6
KE - Kenya 6
LT - Lituania 6
OM - Oman 6
CH - Svizzera 5
GR - Grecia 5
IL - Israele 5
PK - Pakistan 5
PY - Paraguay 5
JM - Giamaica 4
JO - Giordania 4
MY - Malesia 4
UY - Uruguay 4
AL - Albania 3
AZ - Azerbaigian 3
BO - Bolivia 3
DZ - Algeria 3
ET - Etiopia 3
PE - Perù 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
HR - Croazia 2
KH - Cambogia 2
KZ - Kazakistan 2
NI - Nicaragua 2
NP - Nepal 2
PA - Panama 2
PS - Palestinian Territory 2
PT - Portogallo 2
QA - Qatar 2
AO - Angola 1
CG - Congo 1
CR - Costa Rica 1
CY - Cipro 1
DM - Dominica 1
EE - Estonia 1
EU - Europa 1
HN - Honduras 1
HU - Ungheria 1
IR - Iran 1
LV - Lettonia 1
MM - Myanmar 1
MT - Malta 1
MU - Mauritius 1
NA - Namibia 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
ZW - Zimbabwe 1
Totale 7.307
Salva come PNG Salva come JPEG
Città #
Ashburn 704
Singapore 342
Chandler 330
Dallas 197
Fairfield 173
San Jose 157
Hong Kong 142
Jacksonville 139
Dublin 129
Des Moines 120
Ho Chi Minh City 118
New York 111
Boardman 89
Hanoi 85
Wilmington 84
Woodbridge 82
Seattle 77
Los Angeles 74
Beijing 73
Houston 71
Centro 63
Lauterbourg 62
The Dalles 62
Abidjan 60
Moscow 60
Munich 51
Ancona 49
Lawrence 49
Princeton 49
Ann Arbor 46
Cambridge 44
Council Bluffs 41
Redmond 40
San Mateo 33
Orem 31
São Paulo 30
Buffalo 25
Haiphong 25
Rome 24
San Diego 24
Turin 24
Helsinki 23
Milan 23
Tolentino 23
Chicago 22
London 22
Warsaw 22
Washington 20
Chennai 18
Frankfurt am Main 18
Hefei 18
Santa Clara 18
Turku 18
Brooklyn 17
Johannesburg 14
Montreal 14
Tokyo 14
Poplar 13
Da Nang 12
Pune 12
Atlanta 11
Denver 11
Brussels 10
Columbus 10
Manchester 10
Nuremberg 10
Amsterdam 9
Iesi 9
Marche 9
San Francisco 9
Tashkent 9
Baghdad 8
Boston 8
Brasília 8
Cagliari 8
Guangzhou 8
Mexico City 8
Monte San Pietrangeli 8
Mumbai 8
Vienna 8
Wuhan 8
Belo Horizonte 7
Norwalk 7
Shanghai 7
Stockholm 7
Amandola 6
Bắc Ninh 6
Medellín 6
Phoenix 6
Querétaro 6
West Jordan 6
Aversa 5
Biên Hòa 5
Charlotte 5
Comunanza 5
Dhaka 5
Goiânia 5
Guayaquil 5
Jeddah 5
Jesi 5
Totale 4.826
Salva come PNG Salva come JPEG
Nome #
Abnormal liver function tests predict transfer to intensive care unit and death in COVID-19 191
Gut epithelial impairment, microbial translocation and immune system activation in inflammatory bowel disease–associated spondyloarthritis 182
ACCURACY OF DUAL-ENERGY COMPUTED TOMOGRAPHY FOR THE DETECTION OF BONE MARROW EDEMA IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS 180
Increased expression of the ectoenzyme CD38 in peripheral blood plasmablasts and plasma cells of patients with systemic sclerosis 171
Multicenter validation of the DETAIL questionnaire for the screening of spondyloarthritis in patients with inflammatory bowel diseases 166
Clinical and patient reported outcomes of the multidisciplinary management in patients with inflammatory bowel disease-associated spondyloarthritis 159
6 and 12 month outcomes in patients following COVID-19-related hospitalization: a prospective monocentric study 156
Clinical outcomes and feasibility of the multidisciplinary management of patients with psoriatic arthritis: two-year clinical experience of a dermo-rheumatologic clinic 151
Adalimumab efficacy in enteropathic spondyloarthritis: A 12-mo observational multidisciplinary study 150
SARS-COV-2 Infection, Vaccination, and Immune-Mediated Diseases: Results of a Single-Center Retrospective Study 150
Biomarkers in Inflammatory Bowel Disease-Associated Spondyloarthritis: State of the Art and Unmet Needs 149
Effect of Adalimumab Therapy on Both Gastrointestinal and Articular Inflammation at 6 Months in Patients Affected by Enteropathic Spondyloarthritis: Preliminary Results from a Monocentric Prospective Observational Study 148
Sclerostin and Antisclerostin Antibody Serum Levels Predict the Presence of Axial Spondyloarthritis in Patients with Inflammatory Bowel Disease 146
The ATTRACT study: screening for the early identification of axial psoriatic arthritis in a cohort of Italian psoriatic patients 141
Disease course in patients with systemic autoimmune diseases: insights on the safety of immunosuppression during the SARS-CoV-2 outbreak in Italy 139
A validation study of the Simple Psoriatic Arthritis Screening (SiPAS) questionnaire to screen psoriasis patients for psoriatic arthritis 137
The DETection of Arthritis in Inflammatory boweL diseases (DETAIL) questionnaire: development and preliminary testing of a new tool to screen patients with inflammatory bowel disease for the presence of spondyloarthritis 134
Certolizumab pegol for the treatment of psoriasis 134
Patient Reported Outcomes and Quality of Life in a Cohort of Patients Affected by Entheropathic Spondyloarthritis: Preliminary Results from a Monocentric Prospective Observational Study 132
Subcutaneous immunoglobulin in inflammatory myopathies: efficacy in different organ systems 132
A painful diagnosis 129
Systemic Sclerosis: From Pathophysiology to Novel Therapeutic Approaches 128
Biologics in inflammatory immune-mediated systemic diseases 127
Aseptic inflammation of prosthetic knee in a patient affected by rheumatoid arthritis 122
Videofluorography swallow study in patients with systemic sclerosis: correlation with clinical and radiological features 122
Dual-energy computed tomography for the detection of sacroiliac joints bone marrow oedema in patients with axial spondyloarthritis 122
Mycophenolate mofetil-induced colitis in a patient with systemic sclerosis 121
Chronic hepatitis E in a patient treated with rituximab and mycophenolate mofetil for Sjögren's syndrome 119
MULTICENTER VALIDATION OF THE DETECTION OF ARTHRITIS IN INFLAMMATORY BOWEL DISEASES (DETAIL) QUESTIONNAIRE FOR THE SCREENING OF SPONDYLOARTHRITIS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES 119
PDGF/PDGFR: A Possible Molecular Target in Scleroderma Fibrosis 119
Adeno-associated virus type 5 infection via PDGFRα is associated with Interstitial lung disease in systemic sclerosis and generates composite peptides and epitopes recognized by the agonistic immunoglobulins present in patients with systemic sclerosis 115
Putative functional pathogenic autoantibodies in systemic sclerosis 113
Hydroxychloroquine, dermatology, and SARS-CoV-2: Updating an old association 113
Patient reported outcomes and assessment of the quality of life in a cohort of patients affected by enteropathic spondyloarthritis: results of a monocentric prospective observational study at one year 111
Biologics in inflammatory and immunomediated arthritis 110
Increased expression of the ectoenzyme CD38 in peripheral blood plasmablasts and plasma cells of patients with systemic sclerosis 107
A young man with persistent dyspepsia: The unexpected virtue of proton-pump inhibitors 103
Diagnosis and management of leukocytoclastic vasculitis 103
Musculoskeletal and rheumatic diseases induced by immune checkpoint inhibitors: A review of the literature 98
Dolore Articolare Acuto 94
Efficacy and safety of intravenous and subcutaneous tocilizumab in a cohort of patients affected by rheumatoid arthritis in real-life 94
Upadacitinib effectiveness and factors associated with minimal disease activity achievement in patients with psoriatic arthritis: preliminary data of a real-life multicenter study 94
Axial psoriatic arthritis in patients not fulfilling the back pain entry features of the ASAS Classification Criteria for Axial Spondyloarthritis: findings from the ATTRACT Study 92
Current take on systemic sclerosis patients’ vaccination recommendations 90
The neuropathic pain features in Psoriatic Arthritis: a cross-sectional evaluation of prevalence and associated factors 88
New Insights in Physical Therapy and Rehabilitation in Psoriatic Arthritis: A Review 86
Atypical Spontaneous Hematomas in a Patient with Severe Coronavirus Disease 2019 (COVID-19) 84
Hypogammaglobulinemia in patients affected by limited cutaneous systemic sclerosis: Case series and review of the literature 82
Discharge from the emergency department and early hospital revaluation in patients with COVID-19 pneumonia: a prospective study 82
Novel therapeutic approaches and treatment targets for psoriatic arthritis 80
Safety of intermediate dose of low molecular weight heparin in COVID-19 patients 79
Speckle-tracking global longitudinal strain predicts death and cardiovascular events in patients with systemic sclerosis 78
Pre-scleroderma and new opportunities for preventive medicine 78
Screening and Analysis of Possible Drugs Binding to PDGFRα: A Molecular Modeling Study 77
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 77
Skin Gene Expression Profiles in Systemic Sclerosis: From Clinical Stratification to Precision Medicine 76
Statins, ACE/ARBs drug use, and risk of pneumonia in hospitalized older patients: a retrospective cohort study 76
Widespread painful nodules in a patient with rheumatoid arthritis 75
Enteropathic spondyloarthritis: Results from a large nationwide database analysis 75
Atypical neutrophilic panniculitis as presentation of BCR-ABL1-negative chronic myeloid leukaemia 74
Role of cognitive impairment and malnutrition as determinants of quality of life in patients with systemic sclerosis 74
Is there a future for anti-cd38 antibody therapy in systemic autoimmune diseases? 70
Real-life efficacy and safety of nintedanib in systemic sclerosis-interstitial lung disease: data from an Italian multicentre study 66
Tocilizumab for severe COVID-19 pneumonia 66
Inflammatory bowel disease manifestations in spondyloarthritis: considerations for the clinician 65
Skin ultrasound in systemic sclerosis: past, present and exciting future 57
Systemic Sclerosis: A Key Model of Endothelial Dysfunction 55
Prescription of ACE-Is/ARBs in patients with cardio-renal disease: a multicenter retrospective cohort study from the REPOSI registry 48
Doppler ultrasound, a noninvasive tool for the study of mesenteric arterial flow in systemic sclerosis: a cross-sectional study of a patient cohort with review and meta-analysis of the literature 47
Micro- and Macro-Vascular Disease in Systemic Sclerosis and Very Early SSc (VEDOSS): Results from a Monocentric Observational Study 14
Totale 7.542
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.866
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.866
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021145 0 0 0 0 0 0 0 0 0 55 45 45
2021/2022380 23 41 22 6 9 40 6 14 32 36 78 73
2022/2023898 68 103 67 79 44 201 11 53 187 10 59 16
2023/2024622 70 14 51 63 86 139 25 26 9 80 14 45
2024/20251.288 177 91 20 32 68 60 170 58 216 70 149 177
2025/20263.203 287 207 198 335 438 245 579 359 299 256 0 0
Totale 7.542